المؤلفون: Ding, Huiwen¹ (AUTHOR) dhwdeng@163.com, Jiang, Tianqi¹ (AUTHOR), Xie, Haijiao² (AUTHOR), Wang, Jianqiao^1,3 (AUTHOR) wangjq@gzhu.edu.cn, Xiao, Pengfei¹ (AUTHOR) xpfawd@nefu.edu.cn

المصدر: Journal of Colloid & Interface Science. Jan2025:Part C, Vol. 678, p1151-1169. 19p.

مصطلحات موضوعية: *HYDROXYCHLOROQUINE, *REACTIVE oxygen species, *RADICALS (Chemistry), *DENSITY functional theory, *TREATMENT effectiveness

المؤلفون: Yıldız, Oğuzhan¹ dr.oguzhan@outlook.com, Gürbüz, Ali Fuat¹, Karakurt Eryılmaz, Melek¹, Araz, Murat¹, Aykut, Talat¹, Şahin, Özlem², Büyükboyacı, Naciye Hilal³, Çelik, Zeliha³, Artaç, Mehmet¹

المصدر: Journal of Oncology Pharmacy Practice. Jan2025, Vol. 31 Issue 1, p168-171. 4p.

مصطلحات موضوعية: *HYDROXYCHLOROQUINE, *DOCETAXEL, *TRASTUZUMAB, *LYMPHADENECTOMY, *BREAST tumors, *SYSTEMIC lupus erythematosus, *POSITRON emission tomography computed tomography, *TREATMENT effectiveness, *METASTASIS, *MONOCLONAL antibodies, *ZOLEDRONIC acid, *MASTECTOMY

المؤلفون: Hünür, Mehmet¹, Öğüt, Tahir Saygın², Çelik, Ece³, Erbasan, Funda², Dilbil, Melis², Nokay, Mine², Terzioğlu, Mustafa Ender², Yazisiz, Veli² drvyazisiz@yahoo.com.tr

المصدر: Archives of Rheumatology. Dec2024, Vol. 39 Issue 4, p631-640. 10p.

مصطلحات موضوعية: *RISK assessment, *HYDROXYCHLOROQUINE, *PSORIATIC arthritis, *SEX distribution, *SMOKING, *CHEST X rays, *RETROSPECTIVE studies, *INTERSTITIAL lung diseases, *AGE distribution, *LUNG diseases, *DISEASE complications, *SYMPTOMS

المؤلفون: Hagen, Kurtis¹ (AUTHOR) kurtishagen@yahoo.com

المصدر: Accountability in Research: Policies & Quality Assurance. Aug2024, Vol. 31 Issue 6, p600-619. 20p.

مصطلحات موضوعية: HYDROXYCHLOROQUINE, COVID-19 treatment, MEDICAL literature, STATISTICAL significance, MEDICAL logic

المؤلفون: Tillero, Rosana¹, González‐Serrano, José² josego09@ucm.es, Caponio, Vito Carlo Alberto^2,3, Serrano, Julia², Hernández, Gonzalo², López‐Pintor, Rosa María²

المصدر: Oral Diseases. Oct2024, Vol. 30 Issue 7, p4098-4112. 15p.

مصطلحات موضوعية: *HYDROXYCHLOROQUINE, *CHLOROQUINE, *SYSTEMATIC reviews, *MEDLINE, *DRUG efficacy, *MEDICAL databases, *ORAL lichen planus, *ANTIMALARIALS, *ONLINE information services

المؤلفون: Yazdany, Jinoos¹ Jinoos.yazdany@ucsf.edu, Shiboski, Stephen², Schmajuk, Gabriela³

المصدر: Arthritis & Rheumatology. Oct2024, Vol. 76 Issue 10, p1467-1470. 4p.

مصطلحات موضوعية: *HYDROXYCHLOROQUINE, *RISK assessment, *PATIENT safety, *HOSPITAL care, *SYSTEMIC lupus erythematosus, *DRUG efficacy

المؤلفون: Nestor, Jacquelyn¹, Choi, Hyon¹, Mancini, Christian¹, Zhou, Baijun¹, Zhang, Yuqing¹, Costenbader, Karen H.², Jorge, April¹ AMJorge@mgh.harvard.edu

المصدر: Arthritis & Rheumatology. Oct2024, Vol. 76 Issue 10, p1512-1517. 6p.

مصطلحات موضوعية: *HYDROXYCHLOROQUINE, *RISK assessment, *ACADEMIC medical centers, *IMMUNOSUPPRESSIVE agents, *RESEARCH funding, *HOSPITAL care, *LOGISTIC regression analysis, *BODY weight, *SYSTEMIC lupus erythematosus, *DESCRIPTIVE statistics, *CROSSOVER trials, *DOSE-effect relationship in pharmacology, *ODDS ratio, *CONFIDENCE intervals, *GLUCOCORTICOIDS

المؤلفون: Mcknight, Madison¹, Cutshall, B. Tate^2,3, Sakaan, Sami^2,3, Al Hommos, Nisreen Abu⁴, Wells, Drew A.^2,3 drew.wells@mlh.org

المصدر: Journal of Pharmacy Practice. Oct2024, Vol. 37 Issue 5, p1205-1208. 4p.

مصطلحات موضوعية: *HYDROXYCHLOROQUINE, *PREPROCEDURAL fasting, *FOOD consumption, *GLUCOSE tolerance tests, *TREATMENT effectiveness, *BLOOD sugar, *CLINICAL pathology, *ADRENOCORTICOTROPIC hormone, *HYPOGLYCEMIA

المؤلفون: Ergün, Mustafa Çağrı¹ mustafacagriergun@gmail.com, Yılmaz, Okancan², Bilgen, Hakan³, Oltulu, Pembe², Kılınç, Fahriye², Tunç, Recep¹

المصدر: Archives of Rheumatology. Sep2024, Vol. 39 Issue 3, p404-410. 7p.

مصطلحات موضوعية: *RISK assessment, *HYDROXYCHLOROQUINE, *MONONUCLEAR leukocytes, *T-test (Statistics), *AUTOANTIBODIES, *LOGISTIC regression analysis, *RETROSPECTIVE studies, *DESCRIPTIVE statistics, *AGE distribution, *CHI-squared test, *MANN Whitney U Test, *ANTIGENS, *LONGITUDINAL method, *MEDICAL records, *ACQUISITION of data, *SJOGREN'S syndrome, *SALIVARY glands, *COMPARATIVE studies, *DATA analysis software, *DISEASE complications

المؤلفون: Goyal, Mohit¹, Ravindran, Vinod^2,3 drvinod12@gmail.com

المصدر: Rheumatology. Dec2024, Vol. 63 Issue 12, p3208-3210. 3p.

مصطلحات موضوعية: *DRUG therapy for rheumatism, *HYDROXYCHLOROQUINE, *SERIAL publications, *WOMEN, *PREGNANT women, *ANTIRHEUMATIC agents, *PREGNANCY outcomes, *PRECONCEPTION care, *COUNSELING, *EVIDENCE-based medicine, *PREGNANCY

المصدر: Combination of Autophagy Selective Therapeutics (COAST) in Advanced Solid Tumors or Relapsed Prostate Cancer, A Phase I/II Trial

المؤلفون: Oncocross Co. Ltd., CytoGen, Inc.

المساهمون: Changhoon Yoo, Associate Professor

المصدر: A Study of Hydroxychloroquine and Chlorphenesin Carbamate in Combination with MFOLFIRINOX in Inoperable Locally Advanced or Metastatic Pancreatic Cancer

المؤلفون: National Cancer Institute (NCI), American Lebanese Syrian Associated Charities

المصدر: Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine (HCQ) for BRAF V600E-mutant or Trametinib and HCQ for BRAF Fusion/Duplication Positive or NF1-associated Recurrent or Progressive Gliomas in Children and Young Adults

المصدر: Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma Through Image-guided Locoregional Therapy

المؤلفون: Ministry of Health, France

المصدر: Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA)Nephropathy Course QUIgAN Study

المصدر: A Phase II, Blinded, Randomised, Placebo Controlled Clinical Trial to Determine the Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis

المساهمون: Bin Wei, Director

المصدر: Gabapentin Alone and in Combination With Carvedilol for the Treatment of Rosacea-Associated Flushing and Erythema:a Randomized Controlled Clinical Trial

المصدر: Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis: Multicenter, Prospective, Placebo-controlled, Randomized Trial

المصدر: Baricitinib in Calcium PyrophosphAte DePosiTion DIseaSe Trial - a Proof of Concept Phase II Clinical Trial
Krenn V, Morawietz L, Burmester GR, Kinne RW, Mueller-Ladner U, Muller B, Haupl T. Synovitis score: discrimination between chronic low-grade and high-grade synovitis. Histopathology. 2006 Oct;49(4):358-64. doi: 10.1111/j.1365-2559.2006.02508.x.
Krenn V, Morawietz L, Haupl T, Neidel J, Petersen I, Konig A. Grading of chronic synovitis--a histopathological grading system for molecular and diagnostic pathology. Pathol Res Pract. 2002;198(5):317-25. doi: 10.1078/0344-0338-5710261.
Kelly S, Humby F, Filer A, Ng N, Di Cicco M, Hands RE, Rocher V, Bombardieri M, D'Agostino MA, McInnes IB, Buckley CD, Taylor PC, Pitzalis C. Ultrasound-guided synovial biopsy: a safe, well-tolerated and reliable technique for obtaining high-quality synovial tissue from both large and small joints in early arthritis patients. Ann Rheum Dis. 2015 Mar;74(3):611-7. doi: 10.1136/annrheumdis-2013-204603. Epub 2013 Dec 13.
Sirotti S, Terslev L, Filippucci E, Iagnocco A, Moller I, Naredo E, Vreju FA, Adinolfi A, Becce F, Hammer HB, Cazenave T, Cipolletta E, Christiansen SN, Delle Sedie A, Diaz M, Figus F, Mandl P, MacCarter D, Mortada MA, Mouterde G, Porta F, Reginato AM, Schmidt WA, Serban T, Wakefield RJ, Zufferey P, Sarzi-Puttini P, Zanetti A, Damiani A, Pineda C, Keen HI, D'Agostino MA, Filippou G; OMERACT Ultrasound working group-CPPD subgroup. Development and validation of an OMERACT ultrasound scoring system for the extent of calcium pyrophosphate crystal deposition at the joint level and patient level. Lancet Rheumatol. 2023 Aug;5(8):e474-e482. doi: 10.1016/S2665-9913(23)00136-4. Epub 2023 Jul 5.
Terslev L, Naredo E, Aegerter P, Wakefield RJ, Backhaus M, Balint P, Bruyn GAW, Iagnocco A, Jousse-Joulin S, Schmidt WA, Szkudlarek M, Conaghan PG, Filippucci E, D'Agostino MA. Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce-Part 2: reliability and application to multiple joints of a standardised consensus-based scoring system. RMD Open. 2017 Jul 11;3(1):e000427. doi: 10.1136/rmdopen-2016-000427. eCollection 2017.
Uson J, Rodriguez-Garcia SC, Castellanos-Moreira R, O'Neill TW, Doherty M, Boesen M, Pandit H, Moller Parera I, Vardanyan V, Terslev L, Kampen WU, D'Agostino MA, Berenbaum F, Nikiphorou E, Pitsillidou IA, de la Torre-Aboki J, Carmona L, Naredo E. EULAR recommendations for intra-articular therapies. Ann Rheum Dis. 2021 Oct;80(10):1299-1305. doi: 10.1136/annrheumdis-2021-220266. Epub 2021 May 25.
Genovese MC, Smolen JS, Takeuchi T, Burmester G, Brinker D, Rooney TP, Zhong J, Daojun M, Saifan C, Cardoso A, Issa M, Wu WS, Winthrop KL. Safety profile of baricitinib for the treatment of rheumatoid arthritis over a median of 3 years of treatment: an updated integrated safety analysis. Lancet Rheumatol. 2020 Jun;2(6):e347-e357. doi: 10.1016/S2665-9913(20)30032-1.
Caporali R, Taylor PC, Aletaha D, Sanmarti R, Takeuchi T, Mo D, Haladyj E, Bello N, Zaremba-Pechmann L, Fang Y, Dougados M. Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis up to 6.5 years of treatment: results of a long-term study. Rheumatology (Oxford). 2024 Oct 1;63(10):2799-2809. doi: 10.1093/rheumatology/keae012.
Filippou G, Adinolfi A, Cimmino MA, Scire CA, Carta S, Lorenzini S, Santoro P, Sconfienza LM, Bertoldi I, Picerno V, Di Sabatino V, Ferrata P, Galeazzi M, Frediani B. Diagnostic accuracy of ultrasound, conventional radiography and synovial fluid analysis in the diagnosis of calcium pyrophosphate dihydrate crystal deposition disease. Clin Exp Rheumatol. 2016 Mar-Apr;34(2):254-60. Epub 2016 Feb 9.
Abhishek A, Tedeschi SK, Pascart T, Latourte A, Dalbeth N, Neogi T, Fuller A, Rosenthal A, Becce F, Bardin T, Ea HK, Filippou G, Fitzgerald J, Iagnocco A, Liote F, McCarthy GM, Ramonda R, Richette P, Sivera F, Andres M, Cipolletta E, Doherty M, Pascual E, Perez-Ruiz F, So A, Jansen TL, Kohler MJ, Stamp LK, Yinh J, Adinolfi A, Arad U, Aung T, Benillouche E, Bortoluzzi A, Dau J, Maningding E, Fang MA, Figus FA, Filippucci E, Haslett J, Janssen M, Kaldas M, Kimoto M, Leamy K, Navarro GM, Sarzi-Puttini P, Scire C, Silvagni E, Sirotti S, Stack JR, Truong L, Xie C, Yokose C, Hendry AM, Terkeltaub R, Taylor WJ, Choi HK. The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease. Ann Rheum Dis. 2023 Oct;82(10):1248-1257. doi: 10.1136/ard-2023-224575. Epub 2023 Jul 26.
Tedeschi SK, Huang W, Yoshida K, Solomon DH. Risk of cardiovascular events in patients having had acute calcium pyrophosphate crystal arthritis. Ann Rheum Dis. 2022 Aug 11;81(9):1323-1329. doi: 10.1136/annrheumdis-2022-222387.
Kwan A, Ingrid E, Jiang M, Lim KKT. The cardiovascular risk of JAK inhibitors in treating rheumatic diseases. Int J Rheum Dis. 2024 Aug;27(8):e15308. doi: 10.1111/1756-185X.15308. No abstract available.
Ytterberg SR, Bhatt DL, Mikuls TR, Koch GG, Fleischmann R, Rivas JL, Germino R, Menon S, Sun Y, Wang C, Shapiro AB, Kanik KS, Connell CA; ORAL Surveillance Investigators. Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. N Engl J Med. 2022 Jan 27;386(4):316-326. doi: 10.1056/NEJMoa2109927.
Damart J, Filippou G, Andres M, Cipolletta E, Sirotti S, Carboni D, Filippucci E, Diez P, Abhishek A, Latourte A, Ea HK, Ottaviani S, Letarouilly JG, Desbarbieux R, Graf S, Norberciak L, Richette P, Pascart T. Retention, safety and efficacy of off-label conventional treatments and biologics for chronic calcium pyrophosphate crystal inflammatory arthritis. Rheumatology (Oxford). 2024 Feb 1;63(2):446-455. doi: 10.1093/rheumatology/kead228.
Zhang W, Doherty M, Pascual E, Barskova V, Guerne PA, Jansen TL, Leeb BF, Perez-Ruiz F, Pimentao J, Punzi L, Richette P, Sivera F, Uhlig T, Watt I, Bardin T. EULAR recommendations for calcium pyrophosphate deposition. Part II: management. Ann Rheum Dis. 2011 Apr;70(4):571-5. doi: 10.1136/ard.2010.139360. Epub 2011 Jan 20.
T Virtanen A, Haikarainen T, Raivola J, Silvennoinen O. Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases. BioDrugs. 2019 Feb;33(1):15-32. doi: 10.1007/s40259-019-00333-w.
Guerne PA, Terkeltaub R, Zuraw B, Lotz M. Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes. Arthritis Rheum. 1989 Nov;32(11):1443-52. doi: 10.1002/anr.1780321114.
Punzi L, Oliviero F, Ramonda R. Transforming growth factor-beta levels in synovial fluid of osteoarthritis with or without calcium pyrophosphate dihydrate crystals. J Rheumatol. 2003 Feb;30(2):420; author reply 420-1. No abstract available.
Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006 Mar 9;440(7081):237-41. doi: 10.1038/nature04516. Epub 2006 Jan 11.

المصدر: #StayHome: Efficacy of Early Hydroxychloroquine in Outpatients to Reduce Secondary Hospitalisation and Household Transmission of COVID-19 in Switzerland: A Double-blind, Randomised, Placebo-controlled Trial